ID Source | ID |
---|---|
PubMed CID | 10897041 |
CHEMBL ID | 3144379 |
MeSH ID | M0073851 |
Synonym |
---|
2'-deoxyadenylyl-(3'-5')-2'-deoxyadenosine |
CHEMBL3144379 |
Class | Description |
---|---|
purines | A class of imidazopyrimidines that consists of purine and its substituted derivatives. |
nucleoside analogue | An analogue of a nucleoside, being an N-glycosyl compound in which the nitrogen-containing moiety is a modified nucleotide base. They are commonly used as antiviral products to prevent viral replication in infected cells. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID55332 | Percent inhibition of DNA synthesis ([Me-3H] thymidine incorporation) at 50 uM concentration | 1983 | Journal of medicinal chemistry, Dec, Volume: 26, Issue:12 | Structure--activity relationships for and potentiation of the antimitogenic activity of 2-5A core derived from 2-5A, a mediator of interferon action. |
AID164131 | Percent inhibition of protein synthesis ([35S]methionine incorporation) at 50 uM concentration | 1983 | Journal of medicinal chemistry, Dec, Volume: 26, Issue:12 | Structure--activity relationships for and potentiation of the antimitogenic activity of 2-5A core derived from 2-5A, a mediator of interferon action. |
AID55333 | Percent inhibition of DNA synthesis ([Me-3H] thymidine incorporation) at 5 uM concentration | 1983 | Journal of medicinal chemistry, Dec, Volume: 26, Issue:12 | Structure--activity relationships for and potentiation of the antimitogenic activity of 2-5A core derived from 2-5A, a mediator of interferon action. |
AID164132 | Percent inhibition of protein synthesis ([35S]methionine incorporation) at 5 uM concentration | 1983 | Journal of medicinal chemistry, Dec, Volume: 26, Issue:12 | Structure--activity relationships for and potentiation of the antimitogenic activity of 2-5A core derived from 2-5A, a mediator of interferon action. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (42.86) | 18.7374 |
1990's | 6 (42.86) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (7.14%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (92.86%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |